MGIC Investment (NYSE:MTG) Stock

MGIC Investment

MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all 50 states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.

Snap Inc.

News

Downgrades

Pre-Market Outlook

Analyst Ratings

Trading Ideas

RACE

SNAP

WRBY

This Snap Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Pinterest Inc.

Markets

EBAY

PINS

PTVE

This Pinterest Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Earnings

Large Cap

Mid Cap

Dividends

Management

PLMR

MetLife, Inc. (NYSE: MET) benefits on the back of a well-performing Group Benefits business, acquisitions and partnerships, cost-cutting efforts and strong cash balance.

Zacks Rank &amp; Price Performance

MetLife carries a Zacks Rank #2 (Buy) at present.

Analyzing MetLife Stock: Is Buy Strategy the Right Move?

MGIC Investment Corp

WisdomTree Mortgage Plus Bond Fund

MOUNT GIBSON IRON LTD ORD by Mount Gibson Iron Ltd.

Mount Gibson Iron Ltd

MOUNT GIBSN IRON UNSP/ADR by Mount Gibson Iron Ltd.

Barclays analyst Terry Ma maintains MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) with a Equal-Weight and raises the price target from $25 to $26.

Price Target

Barclays Maintains Equal-Weight on MGIC Investment, Raises Price Target to $26

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Mizuho analyst Ben Chaiken downgraded the rating for Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) from Outperform to Neutral but raised the price target from $243 to $263. Hilton Worldwide shares closed at $258.74 on Tuesday. <a href="https://www.benzinga.com/quote/HLT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Compass Point analyst Giuliano Bologna downgraded MGIC Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) from Buy to Neutral and raised the price target from $24 to $27. MGIC Investment shares closed at $25.59 on Tuesday. <a href="https://www.benzinga.com/quote/MTG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Henning Cosman downgraded Ferrari N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RACE#NYSE">RACE</a>) from Overweight to Equal-Weight. Ferrari shares closed at $459.30 on Tuesday. <a href="https://www.benzinga.com/quote/RACE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Paul Lejuez downgraded the rating for Warby Parker Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRBY#NYSE">WRBY</a>) from Neutral to Sell and raised the price target from $19 to $23. Warby Parker shares closed at $26.88 on Tuesday. <a href="https://www.benzinga.com/quote/WRBY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Ken Gawrelski downgraded the rating for Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) from Overweight to Equal-Weight and lowered the price target from $15 to $11. Snap shares closed at $11.60 on Tuesday. <a href="https://www.benzinga.com/quote/SNAP/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying SNAP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="572" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05070554/image-41-1024x572.png" alt="" class="wp-image-766921" style="width:476px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05070554/image-41-1024x572.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05070554/image-41-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05070554/image-41-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05070554/image-41.png 1107w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43460681/jim-cramer-says-no-to-bigbear-ai-recommends-buying-this-tech-stock">Jim Cramer Says No To BigBear.ai, Recommends Buying This Tech Stock</a></li>
</ul>

Compass Point analyst Giuliano Bologna downgrades MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) from Buy to Neutral and raises the price target from $24 to $27.

Compass Point Downgrades MGIC Investment to Neutral, Raises Price Target to $27

MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) released its Q4 earnings on Monday, February 3, 2025 at 04:05 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
MGIC Investment beat estimated earnings by 9.0%, reporting an EPS of $0.72 versus an estimate of $0.66.
Revenue was up $17.49 million from the same period last year.
<h3>Overview of Past Earnings</h3>
In the previous quarter, the company beat on EPS by $0.11, resulting in a 1.0% increase change in the share price the following day.
Here's a look at MGIC Investment's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.66</td>
<td>0.63</td>
<td>0.60</td>
<td>0.57</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.77</td>
<td>0.77</td>
<td>0.65</td>
<td>0.67</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>306.02M</td>
<td>301.06M</td>
<td>300.51M</td>
<td>292.72M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>306.65M</td>
<td>305.28M</td>
<td>294.36M</td>
<td>283.96M</td>
</tr>
</tbody>
</table>

To track all earnings releases for MGIC Investment <a href="https://www.benzinga.com/quote/MTG/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Summary: MGIC Investment Q4

MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) released its Q4 earnings on Monday, February 3, 2025 at 04:05 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
MGIC Investment beat estimated earnings by 9.0%, reporting an EPS of $0.72 versus an estimate of $0.66.
Revenue was up $17.49 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat on EPS by $0.11 which was followed by a 1.0% increase in the share price the next day.
Here's a look at MGIC Investment's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.66</td>
<td>0.63</td>
<td>0.60</td>
<td>0.57</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.77</td>
<td>0.77</td>
<td>0.65</td>
<td>0.67</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>306.02M</td>
<td>301.06M</td>
<td>300.51M</td>
<td>292.72M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>306.65M</td>
<td>305.28M</td>
<td>294.36M</td>
<td>283.96M</td>
</tr>
</tbody>
</table>

To track all earnings releases for MGIC Investment <a href="https://www.benzinga.com/quote/MTG/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MGIC Investment Earnings Review: Q4 Summary

The earnings results for MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) for Q4 were made public on Monday, February 3, 2025 at 04:05 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
MGIC Investment beat estimated earnings by 9.0%, reporting an EPS of $0.72 versus an estimate of $0.66.
Revenue was up $17.49 million from the same period last year.
<h3>Overview of Past Earnings</h3>
The company beat on EPS by $0.11 in the last quarter, resulting in a 1.0% increase share price change the following day.
Here's a look at MGIC Investment's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.66</td>
<td>0.63</td>
<td>0.60</td>
<td>0.57</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.77</td>
<td>0.77</td>
<td>0.65</td>
<td>0.67</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>306.02M</td>
<td>301.06M</td>
<td>300.51M</td>
<td>292.72M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>306.65M</td>
<td>305.28M</td>
<td>294.36M</td>
<td>283.96M</td>
</tr>
</tbody>
</table>

To track all earnings releases for MGIC Investment <a href="https://www.benzinga.com/quote/MTG/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MGIC Investment Earnings Analysis: Q4 Recap

MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) released its Q4 earnings on Monday, February 3, 2025 at 04:05 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
MGIC Investment beat estimated earnings by 9.0%, reporting an EPS of $0.72 versus an estimate of $0.66.
Revenue was up $17.49 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
In the previous quarter, the company beat on EPS by $0.11, resulting in a 1.0% increase change in the share price the following day.
Here's a look at MGIC Investment's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.66</td>
<td>0.63</td>
<td>0.60</td>
<td>0.57</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.77</td>
<td>0.77</td>
<td>0.65</td>
<td>0.67</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>306.02M</td>
<td>301.06M</td>
<td>300.51M</td>
<td>292.72M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>306.65M</td>
<td>305.28M</td>
<td>294.36M</td>
<td>283.96M</td>
</tr>
</tbody>
</table>

To track all earnings releases for MGIC Investment <a href="https://www.benzinga.com/quote/MTG/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Breakdown: MGIC Investment Q4

The Q4 earnings report for MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) was released on Monday, February 3, 2025 at 04:05 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
MGIC Investment beat estimated earnings by 9.0%, reporting an EPS of $0.72 versus an estimate of $0.66.
Revenue was up $17.49 million from the same period last year.
<h3>Overview of Past Earnings</h3>
Last quarter the company beat on EPS by $0.11 which was followed by a 1.0% increase in the share price the next day.
Here's a look at MGIC Investment's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.66</td>
<td>0.63</td>
<td>0.60</td>
<td>0.57</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.77</td>
<td>0.77</td>
<td>0.65</td>
<td>0.67</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>306.02M</td>
<td>301.06M</td>
<td>300.51M</td>
<td>292.72M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>306.65M</td>
<td>305.28M</td>
<td>294.36M</td>
<td>283.96M</td>
</tr>
</tbody>
</table>

To track all earnings releases for MGIC Investment <a href="https://www.benzinga.com/quote/MTG/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: MGIC Investment Q4 Earnings

MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) reported its Q4 earnings results on Monday, February 3, 2025 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
MGIC Investment beat estimated earnings by 9.0%, reporting an EPS of $0.72 versus an estimate of $0.66.
Revenue was up $17.49 million from the same period last year.
<h3>Historical Earnings Summary</h3>
In the previous quarter, the company beat on EPS by $0.11, resulting in a 1.0% increase change in the share price the following day.
Here's a look at MGIC Investment's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.66</td>
<td>0.63</td>
<td>0.60</td>
<td>0.57</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.77</td>
<td>0.77</td>
<td>0.65</td>
<td>0.67</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>306.02M</td>
<td>301.06M</td>
<td>300.51M</td>
<td>292.72M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>306.65M</td>
<td>305.28M</td>
<td>294.36M</td>
<td>283.96M</td>
</tr>
</tbody>
</table>

To track all earnings releases for MGIC Investment <a href="https://www.benzinga.com/quote/MTG/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into MGIC Investment Q4 Earnings

MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.67 by 7.46 percent. This is a 7.46 percent increase over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $301.44 million which missed the analyst consensus estimate of $303.53 million by 0.69 percent. This is a 6.16 percent increase over sales of $283.96 million the same period last year.

Earnings Beats

Earnings Misses

MGIC Investment Q4 2024 Adj EPS $0.72 Beats $0.67 Estimate, Sales $301.44M Miss $303.53M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Tyson Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) is projected to report quarterly earnings at $0.88 per share on revenue of $13.46 billion. 
• Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) is projected to report quarterly earnings at $2.77 per share on revenue of $780.35 million. 
• Alliance Res Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARLP#NASDAQ">ARLP</a>) is likely to report quarterly earnings at $0.67 per share on revenue of $635.60 million. 
• Johnson Outdoors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JOUT#NASDAQ">JOUT</a>) is estimated to report quarterly loss at $1.30 per share on revenue of $104.73 million. 
• Lavoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVRO#NASDAQ">LVRO</a>) is estimated to report quarterly loss at $0.37 per share on revenue of $373.85 million. 
• NAPCO Security Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) is estimated to report quarterly earnings at $0.34 per share on revenue of $49.88 million. 
• Twist Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) is expected to report quarterly loss at $0.63 per share on revenue of $86.95 million. 
• IDEXX Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>) is estimated to report quarterly earnings at $2.40 per share on revenue of $936.68 million. 
<h3>Companies Reporting After The Bell</h3>
• BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) is expected to report quarterly earnings at $0.48 per share on revenue of $524.74 million. 
• New Jersey Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NJR#NYSE">NJR</a>) is estimated to report quarterly earnings at $1.06 per share on revenue of $468.00 million. 
• Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) is likely to report quarterly earnings at $1.77 per share on revenue of $997.10 million. 
• KKR Real Estate Finance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KREF#NYSE">KREF</a>) is likely to report quarterly loss at $0.07 per share on revenue of $34.78 million. 
• Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) is estimated to report quarterly earnings at $2.49 per share on revenue of $813.57 million. 
• Kyndryl Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KD#NYSE">KD</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $3.81 billion. 
• Everest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) is estimated to report quarterly loss at $17.08 per share on revenue of $3.93 billion. 
• Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) is likely to report quarterly earnings at $1.00 per share on revenue of $754.93 million. 
• Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) is likely to report quarterly earnings at $1.40 per share on revenue of $1.63 billion. 
• J&amp;J Snack Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JJSF#NASDAQ">JJSF</a>) is estimated to report quarterly earnings at $0.59 per share on revenue of $360.85 million. 
• Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $691.84 million. 
• Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) is expected to report quarterly earnings at $0.11 per share on revenue of $775.91 million. 
• MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) is expected to report quarterly earnings at $0.66 per share on revenue of $303.53 million. 
• AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) is estimated to report quarterly earnings at $1.10 per share on revenue of $4.11 billion. 
• Capital Southwest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSWC#NASDAQ">CSWC</a>) is likely to report quarterly earnings at $0.62 per share on revenue of $50.62 million. 
• Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) is estimated to report quarterly earnings at $1.18 per share on revenue of $772.98 million. 
• Sun Country Airlines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCY#NASDAQ">SNCY</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $258.04 million. 
• Flexsteel Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLXS#NASDAQ">FLXS</a>) is estimated to report quarterly earnings at $0.74 per share on revenue of $104.61 million. 
• RBB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBB#NASDAQ">RBB</a>) is expected to report quarterly earnings at $0.36 per share on revenue of $28.12 million. 
• NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) is likely to report quarterly earnings at $3.13 per share on revenue of $3.10 billion. 
• Kforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NYSE">KFRC</a>) is projected to report quarterly earnings at $0.59 per share on revenue of $341.43 million. 
• Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) is expected to report quarterly earnings at $0.47 per share on revenue of $160.29 million. 
• NewMarket (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEU#NYSE">NEU</a>) is estimated to report earnings for its fourth quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARLP

BRBR

CSWC

FLXS

IDXX

JJSF

JOUT

KFRC

KREF

LVRO

NSSC

NXPI

PLTR

RMBS

SAIA

SNCY

TWST

Earnings Scheduled For February 3, 2025

Keefe, Bruyette &amp; Woods analyst Bose George maintains MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) with a Market Perform and lowers the price target from $29 to $28.

Keefe, Bruyette & Woods Maintains Market Perform on MGIC Investment, Lowers Price Target to $28

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Piper Sandler analyst Thomas Champion downgraded the rating for Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) from Overweight to Neutral and lowered the price target from $41 to $36. Pinterest shares closed at $33.06 on Monday. See how other analysts view this stock.</li>
<li>Jefferies analyst John Colantuoni downgraded eBay Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) from Hold to Underperform and slashed the price target from $60 to $52. eBay shares closed at $65.14 on Monday. <a href="https://www.benzinga.com/quote/EBAY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George downgraded MGIC Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) from Outperform to Market Perform and maintained the price target of $29. MGIC Investment shares closed at $24.63 on Monday. See how other analysts view this stock.</li>
<li>Wells Fargo analyst Eric Luebchow downgraded Crown Castle Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) from Equal-Weight to Underweight and slashed the price target from $105 to $100. Crown Castle shares closed at $102.00 on Monday. <a href="https://www.benzinga.com/quote/CCI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Anthony Pettinari downgraded the rating for Pactiv Evergreen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTVE#NASDAQ">PTVE</a>) from Buy to Neutral but raised the price target from $13 to $18. Pactiv Evergreen shares closed at $17.36 on Monday. <a href="https://www.benzinga.com/quote/PTVE/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PINS stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="589" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10081424/image-78-1024x589.png" alt="" class="wp-image-685158" style="width:606px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10081424/image-78-1024x589.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10081424/image-78-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10081424/image-78-768x442.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10081424/image-78.png 1100w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42405361/sp-500-nasdaq-retreat-from-record-highs-investor-sentiment-declines-fear-greed-index-remains-in-neutral-zone">S&amp;P 500, Nasdaq Retreat From Record Highs As Nvidia Declines Over Chinese Antitrust Concerns: Fear &amp; Greed Index Remains In &#8216;Neutral&#8217; Zone</a></li>
</ul>

Keefe, Bruyette &amp; Woods analyst Bose George downgrades MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) from Outperform to Market Perform and maintains the price target from $29 to $29.

Keefe, Bruyette & Woods Downgrades MGIC Investment to Market Perform, Maintains Price Target to $29

B of A Securities analyst Mihir Bhatia downgrades MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) from Buy to Underperform and lowers the price target from $26 to $25.

B of A Securities Downgrades MGIC Investment to Underperform, Lowers Price Target to $25

RBC Capital analyst Scott Heleniak maintains MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) with a Sector Perform and lowers the price target from $28 to $27.

RBC Capital Maintains Sector Perform on MGIC Investment, Lowers Price Target to $27

MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.66 by 16.67 percent. The company reported quarterly sales of $306.649 million which beat the analyst consensus estimate of $306.022 million by 0.20 percent. This is a 3.42 percent increase over sales of $296.505 million the same period last year.

MGIC Investment Q3 2024 Adj. EPS $0.77 Beats $0.66 Estimate, Sales $306.649M Beat $306.022M Estimate

Barclays analyst Terry Ma maintains MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) with a Equal-Weight and raises the price target from $23 to $24.

Barclays Maintains Equal-Weight on MGIC Investment, Raises Price Target to $24

MetLife, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/met#NYSE">MET</a>) benefits on the back of a well-performing Group Benefits business, acquisitions and partnerships, cost-cutting efforts and strong cash balance.
<h2>Zacks Rank &amp; Price Performance</h2>
MetLife carries a Zacks Rank #2 (Buy) at present.
The stock has gained 10% in the past three months compared with the industry&#39;s growth of 5.3%. The Zacks Finance sector and the S&amp;P 500 composite index have returned 0.8% and 2.4%, respectively, in the said time frame.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c8/77767.jpg?v=1023352585" />
Image Source: Zacks Investment Research
<h2>Favorable Style Score</h2>
MetLife carries an impressive Value Score of A. Value Score helps find stocks that are undervalued. Back-tested results show that stocks with a Value Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best opportunities in the value investing space.
<h2>Robust Growth Prospects</h2>
The Zacks Consensus Estimate for MetLife&#39;s 2024 earnings is pegged at $8.67 per share, which indicates an improvement of 18.3% from the 2023 reported figure. The consensus mark for revenues is $73.2 billion, implying a rise of 2% from the 2023 figure. MET&#39;s earnings estimates witnessed seven upward revisions over the past 60 days against no downward movement.
The consensus mark for 2025 earnings is pegged at $9.83 per share, suggesting an improvement of 13.4% from the 2024 estimate. The same for revenues is $76.5 billion, hinting at a 4.6% increase from the 2024 estimate.
<h2>Valuation</h2>
Price-to-book (P/B) is one of the multiples used for valuing insurance stocks. Compared with the multiline industry&#39;s trailing 12-month P/B ratio of 2.57, MetLife has a reading of 1.92. It is quite evident that the stock is currently undervalued.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/0a/77768.jpg?v=1057971813" />
Image Source: Zacks Investment Research
<h2>Solid Return on Equity</h2>
Return on equity in the trailing 12 months is currently 21.4%, which is higher than the industry&#39;s average of 16.2%. This substantiates the company&#39;s efficiency in utilizing shareholders&#39; funds.
<h2>Business Tailwinds</h2>
A key revenue contributor is MetLife&#39;s steady premiums, which have been recovering from pandemic-driven declines. Premiums are witnessing a steady increase in the Group Benefits business, wherein it rose 4% year over year in the first half of 2024. Growth has also been robust in its EMEA and Latin America segments, further contributing to the company&#39;s revenue stream.
MetLife&#39;s focus on streamlining its business, coupled with strategic acquisitions and partnerships, is expected to drive long-term growth. The company has expanded its presence in key areas like vision care and pet insurance through acquisitions, such as Versant Health and PetFirst. It has also strengthened its benefits offerings through partnerships with firms like Aura and Nayya.
A strategic push into private credit investments, marked by the acquisition of Raven Capital, and a collaboration with Fidelity Investments on a fixed immediate income annuity further diversify its business portfolio. Additionally, MetLife continues to reduce volatility by divesting capital-intensive units and intensifying focus on high-growth areas. &nbsp;
MetLife&#39;s cost-saving measures have resulted in notable operational improvements. Between 2015 and 2020, the company saw an improvement of 230 basis points in its direct expense ratio. This efficiency trend has continued, with the direct expense ratio remaining below the guided 12.3% in the first half of 2024.
MetLife also benefits from a strong liquidity position, with short-term debt of $390 million as of June 30, 2024, significantly overshadowed by its $20.8 billion in cash and cash equivalents. This financial strength underpins shareholder returns through repurchases and dividend payments. In April 2024, management approved a 4.8% dividend increase.
<h2>Other Stocks to Consider</h2>
Some other top-ranked stocks in the insurance space include CNO Financial Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cno#NYSE">CNO</a>), MGIC Investment Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtg#NYSE">MTG</a>) and Palomar Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plmr#NASDAQ">PLMR</a>), each sporting a Zacks Rank #1 at present.
The bottom line of CNO Financial outpaced estimates in three of the trailing four quarters and missed the mark once, the average surprise being 21.21%. The Zacks Consensus Estimate for CNO&#39;s 2024 earnings suggests 11% year-over-year growth. The consensus mark for CNO Financial&#39;s 2024 earnings has moved north by 3% in the past 30 days.
MGIC Investment&#39;s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 15.59%. The Zacks Consensus Estimate for MTG&#39;s 2024 earnings indicates 9.1% year-over-year growth, while the same for revenues implies an improvement of 4.7%. MGIC Investment&#39;s consensus mark for 2024 earnings has moved north by 2.2% in the past 30 days.
The bottom line of Palomar outpaced estimates in each of the trailing four quarters, the average surprise being 17.10%. The Zacks Consensus Estimate for PLMR&#39;s 2024 earnings suggests 30.9% year-over-year growth, while the same for revenues implies an improvement of 41.6%. The consensus mark for Palomar&#39;s 2024 earnings has moved north by 1.3% in the past 30 days.
Shares of CNO Financial, MGIC Investment and Palomar have gained 24.2%, 22.4% and 18.3%, respectively, in the past three months.
<a href="https://www.zacks.com/stock/news/2336089/analyzing-metlife-stock-is-buy-strategy-the-right-move?cid=CS-BENZ-FT-analyst_blog|rank_focused-2336089">To read this article on Zacks.com click here.</a>

The Zacks Insurance industry is undervalued than the Zacks S&amp;P 500 composite and the Zacks Finance sector. The insurance industry&#39;s price-to-book (the best multiple for valuing insurers because of their unpredictable financial results) of 1.57 was less than the Zacks S&amp;P 500 composite&#39;s P/B of 8.57 and the sector&#39;s P/B of 3.65. Such below-market positioning hints at room for an upside in the days ahead.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/ea/75359.jpg?v=70695623" />
Image Source: Zacks Investment Research
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/21/75358.jpg?v=45396998" />
Image Source: Zacks Investment Research
Thus, before their valuation increases, locating some undervalued stocks with growth potential is wise.
<h2>Driving Forces</h2>
Global commercial insurance rates remained unchanged in the second quarter of 2024, per the Marsh Global Insurance Market Index. Price hikes, operational strength, higher retention, strong renewal and the appointment of retail agents should help write higher premiums. Per Deloitte Insights, gross premiums are estimated to increase sixfold to $722 billion by 2030.
Analysts at Swiss Re Institute predict premium volume to reach $4.6 trillion in 2024 and $4.8 trillion in 2025. Per the Swiss Re Institute, property and casualty insurers are anticipated to enhance profitability in 2024, with industry-wide return on equity (ROE) at 10% so far in 2024. For 2025, the Swiss Re Institute estimates an ROE of more than 10%.
According to Verisk&#39;s Extreme Event Solutions group estimates, U.S. onshore wind property losses from Beryl were within the $2-$3 billion range. Per Allstate, estimated catastrophe losses were $587 million for July alone from 20 events.
Multiline insurers benefit from a diversified portfolio that lowers concentration risk. While higher demand for protection products benefits sales and premiums of life insurance operations, better pricing and increased exposure to intangibles and cyber threats support premium growth of non-life insurance operations. Per the 2024 global insurance outlook published in Financial Services, U.S. demand for catastrophe reinsurance is expected to grow, putting upward pressure on prices.
The insurance industry is rate-sensitive. An improving rate environment is a boon for insurers, especially long-tail insurers. The Fed held interest rates unchanged at 5.25-5.5% at the December FOMC meeting. With a large invested asset base, investment income should remain healthy, even if the Fed cuts rates later this year. Also, the insurance players are investing heavily in technology to improve scale and efficiency. This should help them generate higher margins and improve profitability.
<h2>Price Performance</h2>
The insurance industry has outperformed the Zacks S&amp;P 500 composite as well as the Finance sector in the past year. The insurance industry has gained 31.6%, compared with the Zacks S&amp;P 500 composite and the sector&#39;s increase of 27.8% and 27.1%, respectively.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/97/75360.jpg?v=1273277392" />
Image Source: Zacks Investment Research
Better pricing, prudent underwriting and increased exposure should help insurers retain the momentum and remain well-poised for the longer term.
<h2>Picking the Value Stocks</h2>
With the help of the Zacks Stock Screener, we have selected four insurance stocks with an impressive Value Score of A or B and a Zacks Rank #1 (Strong Buy) or #2 (Buy). Back-tested results have shown that stocks with a favorable Value Score and a solid Zacks Rank are the best investment options.
These stocks with growth potential have witnessed positive estimate revisions, reflecting analysts&#39; confidence in their operational efficiency and a cheaper valuation.
Axis Capital Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axs#NYSE">AXS</a>) provides various specialty insurance and reinsurance products worldwide. AXIS Capital continues to build on its Specialty Insurance, Reinsurance, and Accident and Health to pave the way for long-term growth. Apart from fortifying the casualty and professional lines in the insurance segment, its focus on deploying resources prudently while enhancing efficiencies and improving its portfolio mix and underwriting profitability bodes well. The expected long-term earnings growth rate is 27.8%. 
This insurer surpassed earnings estimates in each of the last four quarters, the average beat being 94.62%. AXS currently sports a Zacks Rank #1. AXS has a Value Score of A.
The company&#39;s return on equity in the trailing 12 months was 19.7%. AXS also has an impressive VGM Score of A.
Axis Capital&#39;s P/B ratio is 1.26. The Zacks Consensus Estimate for 2024 earnings has moved north 6.8% in the past 30 days, and the estimate indicates a year-over-year increase of 8.6%. AXS shares have gained 40.4% in the past year.
NMI Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmih#NASDAQ">NMIH</a>) provides private mortgage insurance through its wholly-owned insurance subsidiaries in the United States. Improving mortgage insurance portfolio, higher new insurance written volume, a comprehensive reinsurance program, a solid capital position and effective capital deployment poise the insurer well for growth. The expected long-term earnings growth rate is pegged at 9.8%.
The stock currently has a P/B ratio of 1.55. The Zacks Consensus Estimate for 2024 earnings has moved north by 1.1% in the past seven days, and the estimate indicates a year-over-year increase of 16.9%. Its shares have gained 39.8% in the past year. It has a Zacks Rank of 2 and a Value Score of B.
The insurer&#39;s return on equity in the trailing 12 months was 18.2% and it surpassed earnings estimates in each of the last four quarters, the average beat being 10.15%.
MGIC Investment Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtg#NYSE">MTG</a>) is the largest private mortgage insurer in the United States. Higher insurance in force, resulting from an increase in new business written, higher annual persistency, a decline in loss and claims payments, lower delinquency, better housing market fundamentals and prudent capital deployment, bode well for growth. The expected long-term earnings growth rate is pegged at 6.8%.
The stock currently has a P/B ratio of 1.26. The Zacks Consensus Estimate for 2024 earnings has moved north by 2.2% in the past seven days, and the estimate for earnings per share indicates a year-over-year increase of 9.1%. Its shares have gained 43% in the past year. It has a Zacks Rank of 1 and a Value Score of B. The insurer&#39;s return on equity in the trailing 12 months was 14.9% and it surpassed earnings estimates in each of the last four quarters, the average beat being 15.59%.
Old Republic International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ori#NYSE">ORI</a>) specializes in insurance underwriting and related services, operating primarily in the United States and Canada. ORI&#39;s solid market presence, niche focus, low property catastrophe exposure in its General Insurance segment and robust capital position bodes well for growth. ORI continues to strengthen its balance sheet by improving its cash balance while lowering its leverage ratio. Earnings have grown 10.3% in the past five years, better than the industry average of 9%.
The stock currently has a P/B ratio of 1.51. The Zacks Consensus Estimate for 2024 earnings has moved north by 4.4% in the past 30 days, and the estimate indicates a year-over-year increase of 7.6%. Its shares have gained 29.4% in the past year. It has a Zacks Rank of 2 and a Value Score of B. The insurer&#39;s return on equity in the trailing 12 months was 12.5% and it surpassed earnings estimates in three of the last four quarters and missed in one, the average beat being 9.06%.
<a href="https://www.zacks.com/stock/news/2327035/4-low-price-to-book-stocks-from-the-undervalued-insurance-industry?cid=CS-BENZ-FT-analyst_blog|industry_focus-2327035">To read this article on Zacks.com click here.</a>

NMIH

4 Low Price-to-Book Stocks From the Undervalued Insurance Industry

Insurance

Press Releases

MGIC Investment Corporation Announces an Increase to Quarterly Dividend

MGIC Investment Corporation Reports Second Quarter 2024 Results

MGIC Comments on the Recently Adopted PMIERs Updates

AM Best Upgrades Credit Ratings of Operating Subsidiaries of MGIC Investment Corporation

MGIC Investment Corporation Schedules 3rd Quarter 2024 Earnings Call

MGIC Investment Corporation Announces Quarterly Dividend of $0.13 Per Share

MGIC Investment Corporation Reports Third Quarter 2024 Results

MGIC Investment Corporation Schedules 4th Quarter 2024 Earnings Call

MGIC Investment Corporation Reports Fourth Quarter 2024 Results

Enact Holdings

Federal Agricultural Mortgage Corporation Common Stock

Federal Agricultural

Better Home & Finance Holding Company - Class A Common Stock

Better Home & Finance

CNFinance Holdings Limited American Depositary Shares, each representing twenty (20) Ordinary Shares

CNFinance Hldgs

Mr. Cooper Gr

Essent Group

Finance of America Companies Inc. Class A Common Stock

Finance of America

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Comments

MGIC Investment

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga